Grace Life-Tech Holdings Limited has announced significant steps in its ongoing restructuring process aimed at resolving its going concern issue. Since March 31, 2025, the company has focused on expanding its plant stem cell business by enhancing sales channels and seeking strategic supplier investments. Additionally, the company has implemented cost-saving measures, such as optimizing workforce efficiency and conducting remuneration reviews. Grace Life-Tech is also preparing a comprehensive debt restructuring proposal, including debt compromise and debt-to-equity conversion. The company is in talks with a private equity investment fund in Beijing to explore potential collaboration on restructuring plans. Furthermore, negotiations are underway with a potential strategic partner to enhance the company's business presence in China.